JACC: CardioOncology – The Association of Sodium Glucose Cotransporter-2 Inhibitors with Cardiovascular Outcomes in Anthracycline-Treated Patients with Cancer
Episode Description
Commentary by Dr. Ron Witteles
We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies